Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
1993 1
1999 2
2003 1
2004 1
2005 1
2006 1
2007 2
2008 1
2009 3
2012 1
2013 1
2014 2
2015 3
2019 2
2020 2
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Eyelash trichomegaly: a systematic review of acquired and congenital aetiologies of lengthened lashes.
Hutchison DM, Duffens A, Yale K, Park A, Cardenas K, Mesinkovska NA. Hutchison DM, et al. J Eur Acad Dermatol Venereol. 2022 Apr;36(4):536-546. doi: 10.1111/jdv.17877. Epub 2021 Dec 31. J Eur Acad Dermatol Venereol. 2022. PMID: 34919300 Review.
Inclusion criteria were defined as (i) human studies involving congenital and acquired diseases in which eyelash trichomegaly is a characteristic or (ii) assessment of trichomegaly as an adverse or desired effect of a medication or procedure. ...While the most commo …
Inclusion criteria were defined as (i) human studies involving congenital and acquired diseases in which eyelash trichomegaly is a ch …
Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis.
Vij A, Bergfeld WF. Vij A, et al. Clin Dermatol. 2015 Mar-Apr;33(2):217-26. doi: 10.1016/j.clindermatol.2014.10.013. Clin Dermatol. 2015. PMID: 25704941 Review.
Madarosis refers to loss of the eyebrows or eyelashes; milphosis refers specifically to eyelash loss. Excess growth of eyelash hair is termed trichomegaly. Excess skin in the upper or lower eyelids is called dermatochalasis. ...
Madarosis refers to loss of the eyebrows or eyelashes; milphosis refers specifically to eyelash loss. Excess growth of eyelash hair is terme …
Alopecia and Hair Damage Induced by Oncological Therapy.
Jedličková H, Vokurka S, Vojtíšek R, Malečková A. Jedličková H, et al. Klin Onkol. 2019 Fall;32(5):353-359. doi: 10.14735/amko2019353. Klin Onkol. 2019. PMID: 31610668 Review. English.
Targeted therapy and immunotherapy can cause immune-mediated alopecia such as alopecia areata and scarring alopecia as well as paradoxically hypertrichosis and trichomegaly. Physical and pharmacological approaches can be used to prevent and treat alopecia; however, their e …
Targeted therapy and immunotherapy can cause immune-mediated alopecia such as alopecia areata and scarring alopecia as well as paradoxically …
Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma.
Kim JS, Blizzard S, Woodward JA, Leyngold IM, Liss J, Freedman SF. Kim JS, et al. Ophthalmol Glaucoma. 2020 Jul-Aug;3(4):288-294. doi: 10.1016/j.ogla.2020.03.009. Epub 2020 Apr 3. Ophthalmol Glaucoma. 2020. PMID: 33008561
., conjunctival hyperemia, iris heterochromia, and buphthalmos), (2) palpebral (e.g., eyelash trichomegaly, eyelash hypertrichosis, eyelid erythema, eyelid edema, eyelid hyperpigmentation, high upper eyelid crease, upper eyelid ptosis, upper and/or lower eyelid retraction, …
., conjunctival hyperemia, iris heterochromia, and buphthalmos), (2) palpebral (e.g., eyelash trichomegaly, eyelash hypertrichosis, e …
Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.
Celik T, Kosker M. Celik T, et al. Cont Lens Anterior Eye. 2015 Feb;38(1):59-60. doi: 10.1016/j.clae.2014.08.005. Epub 2014 Sep 22. Cont Lens Anterior Eye. 2015. PMID: 25249292 Review.
This report presents a case of erlotinib induced eyelash trichomegaly and the other ocular side effects of this drug in a 74 year-old female patient with metastatic lung adenocarcinoma. Trichomegaly is not a drug-limiting side effect, however long eyelashes often ca …
This report presents a case of erlotinib induced eyelash trichomegaly and the other ocular side effects of this drug in a 74 year-old …
Dermatological side effects of targeted antineoplastic therapies: a prospective study.
Agirgol S, Çaytemel C, Pilanci KN. Agirgol S, et al. Cutan Ocul Toxicol. 2020 Dec;39(4):380-384. doi: 10.1080/15569527.2020.1833028. Epub 2020 Oct 20. Cutan Ocul Toxicol. 2020. PMID: 33028137 Clinical Trial.
Xerosis was present in two cases, and paronychia, pyogenic granuloma, trichomegaly, and madarosis were observed in one patient each. The patients who developed an acneiform rash were treated with topical and systemic antibiotics, light keratolytics, and emollients. ...
Xerosis was present in two cases, and paronychia, pyogenic granuloma, trichomegaly, and madarosis were observed in one patient each. …
Progressive trichomegaly.
Vano-Galvan S, Moreno-Martin P, Jaén P. Vano-Galvan S, et al. Neth J Med. 2009 Jan;67(1):35-6. Neth J Med. 2009. PMID: 19155549 Free article. No abstract available.
Oliver McFarlane syndrome: two new cases and a review of the literature.
Lisbjerg K, Andersen MKG, Bertelsen M, Brost AG, Buchvald FF, Jensen RB, Bisgaard AM, Rosenberg T, Tümer Z, Kessel L. Lisbjerg K, et al. Ophthalmic Genet. 2021 Aug;42(4):464-473. doi: 10.1080/13816810.2021.1904419. Epub 2021 Apr 5. Ophthalmic Genet. 2021. PMID: 33818269 Review.
BACKGROUND: Oliver McFarlane syndrome is a rare syndrome. Clinical presentations include trichomegaly, chorioretinal degeneration, pituitary hormone deficits, and neurological manifestations. ...Both individuals were born preterm and presented with prolonged neonatal respi …
BACKGROUND: Oliver McFarlane syndrome is a rare syndrome. Clinical presentations include trichomegaly, chorioretinal degeneration, pi …
Acquired trichomegaly in uveitis.
Bayer A, Bagkesen H, Sobaci G. Bayer A, et al. Can J Ophthalmol. 2007 Feb;42(1):101-6. Can J Ophthalmol. 2007. PMID: 17361249
BACKGROUND: Various mediators inducing positive effects on eyelash growth (trichomegaly) have been shown to contribute to the pathogenesis of ocular inflammation. ...Steroid use, systemic involvement, number of attacks, and laterality in uveitis patients had no effect on e …
BACKGROUND: Various mediators inducing positive effects on eyelash growth (trichomegaly) have been shown to contribute to the pathoge …
Trichomegaly induced by topical tacrolimus for the treatment of periorbital vitiligo: A brief report of a new adverse effect.
Molés-Poveda P, Cowen EW. Molés-Poveda P, et al. Pediatr Dermatol. 2019 Jul;36(4):e95-e96. doi: 10.1111/pde.13825. Epub 2019 May 9. Pediatr Dermatol. 2019. PMID: 31070265 Review.
Trichomegaly is a known adverse effect of systemic administration of cyclosporine but is less commonly associated with systemic tacrolimus or with topical calcineruin inhibitors. In this report, we describe the first case, to our knowledge, of trichomegaly due to lo …
Trichomegaly is a known adverse effect of systemic administration of cyclosporine but is less commonly associated with systemic tacro …
26 results